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Immuno-analysis of microparticles: 
probing at the limits of detection
Sharissa L. Latham1,2, Natalia Tiberti1, Naveena Gokoolparsadh3, Karen Holdaway4, 
Pierre Olivier Couraud5,6,7, Georges E. R. Grau1 & Valery Combes1,8
Microparticle (MP) research is clouded by debate regarding the accuracy and validity of flow 
cytometry (FCM) as an analytical methodology, as it is influenced by many variables including 
the pre-analytical conditions, instruments physical capabilities and detection parameters. This 
study utilises a simplistic in vitro system for generating MP, and through comparative analysis 
with immuno-electron microscopy (Immuno-EM) assesses the strengths and limitations of probe 
selection and high-sensitivity FCM. Of the markers examined, MP were most specifically labelled 
with phosphatidylserine ligands, annexin V and lactadherin, although only ~60% MP are PS positive. 
Whilst these two ligands detect comparable absolute MP numbers, they interact with the same 
population in distinct manners; annexin V binding is enhanced on TNF induced MP. CD105 and CD54 
expression were, as expected, consistent and enhanced following TNF activation respectively. Their 
labelling however accounted for as few as 30–40% of MP. The greatest discrepancies between FCM 
and I-EM were observed in the population solely labelled for the surface antigen. These findings 
demonstrate that despite significant improvements in resolution, high-sensitivity FCM remains 
limited in detecting small-size MP expressing low antigen levels. This study highlights factors to 
consider when selecting endothelial MP probes, as well as interpreting and representing data.
The biological significance of membrane microparticles (MP) is increasingly demonstrated across a 
broad range of pathologies, where their elevated levels in patient plasma are indicative of cellular stress 
and disease severity. MP are distinguished from other extracellular vesicles (i.e. exosomes and apoptotic 
bodies) by their derivation from the cells plasma membrane and their submicron size range. Endothelial 
MP have displayed diagnostic potential in cases of preeclampsia, Churg-Strauss syndrome and pulmo-
nary hypertension, along with prognostic value as predictors of atherosclerotic events, cardiovascular 
risk, haemodynamic stress and heart failure1–5.
Flow cytometry (FCM) is the most commonly employed method for MP analysis. Notable benefits 
include that large MP numbers may be analysed quickly, size gating provides a way for eliminating large 
cellular debris and other cell types from the analysis without the need for MP purification, and that 
numerous antigens (Ag)/markers can be detected simultaneously on a single MP. Appropriate probe 
selection poses a considerable challenge for MP quantification. Conventionally, annexin V conjugates 
have been used as they bind phosphatidylserine (PS), a negatively charged phospholipid exposed on the 
plasma membrane during vesiculation6–9. More recently lactadherin has become the preferred probe for 
this MP hallmark as it is reported to be more sensitive to PS and is compatible with calcium chelators 
such as EDTA10–13. Numerous reports have however detailed that large proportions of MP are in fact PS 
negative and do not bind either annexin V or lactadherin, raising concerns for the use of PS labels in 
MP detection and analysis13–18.
1Vascular Immunology Unit, Sydney Medical School, The University of Sydney, NSW, Australia. 2Institute for 
Biophysical Chemistry, Hannover Medical School, Hannover, Germany. 3Australian Centre for Microscopy and 
Microanalysis, The University of Sydney, NSW, Australia. 4Beckman Coulter Australia, 23-27 Chaplin Drive, Lane 
Cove West, NSW 2066, Australia. 5Inserm, U1016, Institut Cochin, Paris, France. 6Cnrs, UMR8104, Paris, France. 
7Univ Paris Descartes, Paris, France. 8Faculty of Science, School of Life Sciences, University of Technology Sydney, 
NSW, Australia. Correspondence and requests for materials should be addressed to V.C. (email: valery.combes@
uts.edu.au or valery.combes@sydney.edu.au)
received: 26 June 2015
Accepted: 07 October 2015
Published: 10 November 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:16314 | DOI: 10.1038/srep16314
An alternative labelling approach is to target surface Ag that are expressed on the cell membrane 
when MP are shed. This method is favourable for plasma samples where MP are derived from many 
cellular origins and it is essential to discern their lineage. Endothelial surface markers utilised to dif-
ferentiate endothelial MP include CD31 (PECAM-1), CD51 (Integrin α V), CD54 (ICAM-1), CD62E 
(E-selectin), CD105 (Endoglin), CD106 (VCAM-1), CD144 (VE Cadherin), CD146 (MCAM)14,19,20. Of 
these, CD105 and CD144 are the only constitutive markers not expressed by other circulating cell types. 
Whilst each of these markers is routinely used for FCM, no thorough morphological characterisation and 
quantitative assessment has been undertaken to assess probe suitability for MP analysis.
Along with probe selection, MP analysis is also greatly influenced by other pre-analytical and analyt-
ical variables, although substantial efforts have been made to standardise methodologies such as sample 
collection, storage, immuno-phenotyping and cytometer calibration across the field20–23. The primary 
disadvantage of standard FCM detectors remains their limited ability to resolve events below 0.5 μ m, 
differentiate background noise from true MP and distinguish coincident events. Various reports have 
demonstrated that technological advances in new generation cytometers and modified approaches in 
detection triggering improve the sensitivity of this method17,24–26. Robert et al. specifically showed that 
the high-sensitivity FCM achieved with the Gallios cytometer, employing a wide2 forward scatter detec-
tor to improve dynamic range, permitted the quantification of small-size MP. Their findings have how-
ever not be corroborated by additional methods, and as such the limitations and strengths of these 
technological advances remain undescribed.
The study aims to assess two specific concerns regarding MP quantification; probe selection and the 
limitations of MP detection in high-sensitivity FCM. To address this we 1) investigated select constitutive 
and inducible endothelial MP probes by FCM, assessing MP numbers and surface expression levels, 2) 
phenotypically characterised MP and marker expression by immuno-electron microscopy (immuno- 
EM) and 3) compared quantitative assessments of the two sets of findings.
Results
FCM characterisation of endothelial MP. MP in resting and TNF-stimulated conditions were dou-
ble labelled for PS (annexin V or lactadherin) and a surface Ag (CD105 or CD54). MP numbers positive 
for either or both markers were recorded and are represented in Table 1 along with the calculated per-
centages of positive MP for the various markers. TNF stimulation significantly increased the numbers of 
MP detected by the PS markers whether they appeared single or double stained (Fig. 1a). In all combina-
tions, both lactadherin and annexin V detected similar numbers of MP as shown in Fig. 1a and Table 1. 
Moreover, a highly significant correlation between these numbers was observed (Fig. 1b).
NS TNF NS TNF
Annexin V Lactadherin
CD54 and PS dual labelled samples (mean MP number/103 cells ± SEM)
 CD54 3.7 ± 0.3 9.1 ± 0.8 3.2 ± 0.3 9.7 ± 1.5
 PS 129.8 ± 5.8 235.1 ± 2.6* 108 ± 5 186 ± 6.9*
 Double 78.9 ± 3.4 220.9 ± 14.4* 88.2 ± 3.3 239.2 ± 14.9*
 Total 212.5 ± 8.6 465.1 ± 21.2* 199.4 ± 7.4 435.4 ± 16.2*
CD105 and PS dual labelled samples (mean MP number/103 cells ± SEM)
 CD105 8.2 ± 0.5 8.3 ± 0.3 9.87 ± 1.8 22.5 ± 3.7*
 PS 158 ± 10.8 347.3 ± 9.8* 121.2 ± 5.8 250.3 ± 12.4*
 Double 61.5 ± 2.5 130.1 ± 7.4* 78.1 ± 3.6 185.1 ± 9.7*
 Total 231 ± 11.3 485.8 ± 3.7* 209.2 ± 8.9 457.9 ± 23.2*
Fluorescence positivity for individual labels (% positive (% range))
 PS 31 (24–44) 48 (41–62) 44 (8–69) 52 (21–72)
 CD54# NS: 17 (5–34) TNF: 25 (17–45)
 CD105# NS: 13 (3–32) TNF: 17 (9–33)
Fluorescence positivity for multiple labels (% positive ± SEM)
 CD54/PS 37 ± 0.8 47 ± 1.6 44 ± 0.9 54 ± 1.7
 CD105/PS 28.4 ± 1.5 27.1 ± 1.1 37.6 ± 1.2 37.1 ± 1.3
Table 1.  The numbers and percentages of MP as assessed by FCM. *Significant difference between non-
stimulated (NS) and TNF activated conditions, Mann-Whitney test, p < 0.05. #Data collated from both 
Annexin V and Lactadherin labelled experiments.
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A small minority of the CD54 + MP were labelled with CD54 only, both in resting and stimulated 
conditions (~4% for all combinations), while in resting conditions an average of 95% and 96% of 
CD54 + MP were double labelled with annexin V and lactadherin, respectively. However, MP positive 
for PS only represented 62% and 59% of the total MP detected with annexin V and lactadherin, respec-
tively. These percentages, in stimulated conditions, were 51.5% and 43.7% for annexin V and lactadherin, 
respectively. CD105 gave a similar labelling profile with a large majority (88–92% depending on the 
Figure 1. Endothelial MP quantitation and characterisation by FCM. Culture supernatants were collected 
from control or TNF activated (100 ng/ml overnight) hCMEC/D3 cells and labelled with either annexin 
V-FITC or lactaherin-FITC in combination with either CD54-PE or CD105-PE. (a) The total numbers 
of MP per 103 cells are shown with dark grey bars representing the levels of PS + MP, light grey bars 
representing double + MP and white bars indicating the numbers of Ag + MP. Annexin V is shown on the 
left hand side of each graph vs lactadherin on the right, CD54 is on top and CD105 below (mean ± SE; 
*p < 0.05, **p < 0.01, ***p < 0.0001). (b) The numbers of annexin V and lactadherin positive MP per 
103 cells were compared between the 6 replicate wells analysed over 3 individual experiments (n = 18). 
Spearman’s test shows a significant correlation between the two PS labels (r = 0.96; p < 0.0001). (c) Mean 
fluorescence intensity (MFI) data for each individual label were pooled (n = 36) and differences between 
resting (NS) and TNF MP were assessed (mean ± SE; ***p < 0.0001). (d) Median fluorescence intensity for 
arbitrary size gates (a–e) (smallest to largest) for each individual label (mean ± SE; *p < 0.05, **p < 0.01, 
***p < 0.001, ***p < 0.0001).
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combinations) of CD105 + MP being double labelled with either PS marker. The proportion of PS marker 
alone was more important within the CD105 staining (72%).
It is important to note that the percentage of the labelled population represented within the total 
number of events detected by the cytometer could vary significantly depending on the combinations of 
markers used (Table 1). CD54 and CD105 positive MP could represent as little as 5 and 3% of the total 
events when observed in combination with annexin V and lactadherin.
The level of fluorescence of the MP population in the resting vs stimulated conditions was then ana-
lysed regardless of whether they were double or single stained (Fig.  1c). The annexin V+ population 
showed a significant increase in mean fluorescence intensity (MFI) following stimulation (p < 0.0001), 
while the other PS marker, lactadherin showed no change. Among the surface Ag, CD54 MFI was signifi-
cantly increased (p < 0.0001), while CD105 remained unchanged. When arbitrary size gates were defined 
and the corresponding median fluorescence recorded we observed that, in stimulated conditions, for all 
surface markers the level of fluorescence was significantly higher as relative size increased (Fig. 1d). The 
greatest differences in the level of fluorescence between relative size gates were observed with annexin V 
labelling with a 2.17-fold increase between gates A (smallest) and E (largest). Lactadherin had a smaller 
fold change between gates A and E of 1.33-fold, with greater inter-size variation seen. Although signifi-
cant, levels of fluorescence of CD54 and CD105 only increase by 1.25- and 1.09-fold, respectively.
Endothelial MP size distribution. Purified MP from resting and TNF-activated hCMEC/D3 were 
subsequently examined by immuno-EM. Heterogeneity in intra-sample size and density is demonstrated 
in Fig. 2a, a representative low magnification micrograph of negatively stained MP from TNF-activated 
hCMEC/D3. Across the 16 experimental groups in this EM analysis, 6.87% ± 5.07 (SD) of events were 
eliminated for falling under the 0.1 μ m MP size limit and 0.14% ± 0.41 exceeded the 2 μ m range. Of 
the 1690 events which fell within the set dimensional boundaries, 2.20% ± 1.76 were within the 1–2 μ m 
range. MP diameters ranged from 0.11–1.93 μ m and 0.10–1.79 μ m for the maximum and minimum 
Feret values, respectively. A significant correlation between these measurements was observed (Fig. 2b, 
Spearman’s coefficient r = 0.96, p < 0.0001), demonstrating that we are examining a distinct population 
of vesicles with proportional maximum and minimum sizes. Furthermore, the equation of the best fit 
line, where y = 1.2167x + 0.0167, supports that these MP are spherical and not augmented. The respec-
tive mean, median and mode of the maximum (0.34; 0.26; 0.19) and minimum (0.26; 0.20; 0.15) diam-
eters (in μ m) indicate that MP from the hCMEC/D3 are most concentrated in the lower end of the size 
range. No significant differences in MP size distribution were observed between the resting and TNF 
activated conditions (Fig. 2c; Mann-Whitney test, p = 0.38).
MP characterisation by quantitative immuno-EM. The four markers of interest, annexin V, lac-
tadherin, CD54 and CD105, were examined separately on the MP surface by immunogold labelling. 
Positively labelled events are shown in Fig. 3a with closed arrow-heads, whilst MP negative for gold par-
ticles are marked with open arrow-heads. CD235a (Glycophorin A), an erythrocyte specific Ag (used as 
an isotype-matched control), and the secondary Ab alone showed no non-specific gold-labelling amongst 
samples. Quantification of gold particles showed a significant correlation between elevated numbers of 
gold bound per MP and increased MP diameter. This was true for each of the markers examined, where 
the Spearman correlation test gave r values of 0.68, 0.51, 0.48 and 0.40 for annexin V, lactadherin, CD54 
Figure 2. Quantitative EM shows no influence of vesiculation agonist on MP size. (a) Representative 
transmission electron micrograph of purified, negatively stained MP collected with the JEOL 1400 TEM 
at 20 000 X Mag. (b) Minimum vs maximum Feret diameters (μ m) for all MP analysed (n = 1690) with 
Image J software, illustrating overall endothelial MP size distribution. A significant correlation was 
confirmed between the two parameters (Spearman’s r = 0.96; p < 0.0001). (c) No significant differences in 
the distribution (Median, 25–75% percentile and range) of maximum Feret diameters (μ m) between resting 
(NS) and TNF MP were observed (Mann Whitney test; p = 0.38).
www.nature.com/scientificreports/
5Scientific RepoRts | 5:16314 | DOI: 10.1038/srep16314
and CD105 respectively, and p< 0.0001 in each case (see Fig. 3b for annexin V # gold vs diameter cor-
relation data).
Annexin V positive MP made up 64% ± 16 of the 552 events counted, with a median diameter 
(Feret’s maximum) of 0.30 μ m (range: 0.12–1.79 μ m), compared with the negative fractions which ranged 
from 0.11–0.65 μ m (median: 0.18 μ m). A similar trend is observed with lactadherin, where PS positive 
MP comprise 62.4% ± 5 of the total MP, ranging in maximum diameter from 0.12–1.85 μ m (median 
0.37 μ m), compared with the negative fractions which had a median diameter of 0.17 μ m (range: 0.11–
0.70 μ m). No differences between the percentages of PS positive MP were observed between resting 
and TNF-stimulated. Differential surface Ag expression between resting and TNF was only observed 
with CD54 labelling, where 22% ± 4 and 38.3% ± 11 of total MP were Ag positive, respectively. CD54 
negative MP were 0.23 μ m in diameter (range: 0.1–1.10 μ m) while positive MP were 0.43 μ m (range: 
0.14–1.79 μ m). Only 19.4% ± 3.00 of MP were CD105 positive across three experiments. Consistent with 
the other markers, MP positive for an Ag had a larger size distribution (median: 0.41 μ m and range: 
0.12–1.93 μ m) compared with the Ag negative population (median: 0.23 μ m and range: 0.1–1.10 μ m). 
The Mann-Whitney test confirmed this significant size difference between gold-positive and negative 
MP, with p < 0.0001 for each of the markers examined (Fig. 3c).
The numbers of gold particles bound to resting (NS) vs TNF derived MP (Table 2) was tested with 
the Kolmogorov-Smirnov test for frequency distribution. No significant differences between the two 
distributions were observed for lactadherin (p = 0.734) or CD105 (p = 0.998). Distinct variations were 
however observed in the annexin V and CD54 labelled samples, where higher numbers of gold were 
associated with MP from TNF activated hCMEC/D3 (p = 0.010 and p < 0.0001, respectively).
Figure 3. A direct correlation between MP size and marker expression. (a) Immuno-gold labelled MP 
grids were imaged at 60 000X Mag with the JEOL 1400 TEM. All images are to the same scale where scale 
bars are measured in micron. Closed arrow-heads indicate gold positive MP whilst open arrow-heads 
indicate gold-negative MP. (b) Spearman’s correlation shows a significant relationship between the size of 
MP, measured as the maximum Feret diameter (μ m), and the number of gold particles bound per MP for 
the annexin V label (r = 0.68; p < 0.0001). (c) The median size, measured as the maximum Feret diameter in 
μ m, was compared between gold-positive and gold-negative MP for each of the markers of interest (Mann 
Whitney test; ***p < 0.0001).
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Comparative FCM and immuno-EM of dual labelled endothelial MP. PS and surface Ag expres-
sion were examined in combination with a dual immunogold labelling method utilising 10 and 15 nm 
gold particles. Figure 4a shows representative images of MP from TNF activated hCMEC/D3 dual tagged 
for annexin V or lactadherin (10 nm gold, closed arrow-heads), and CD105 or CD54 (15 nm gold, open 
arrow-heads). The numbers of PS +, double +, and Ag + MP were enumerated and expressed as a per-
centage of the total number of positive MP counted (Fig.  4b,c; right EM column). A comparison of 
these with the FCM data (Fig. 4b,c) show that in each sample PS labels the majority (> 75%) of marker 
positive events. The trend for CD54+ MP to increase between resting and TNF conditions is consistent 
between FCM and immuno-EM, as is the percentage of CD105 which is unchanged by TNF activation.
Labelling
NS TNF
P Value*n Median # Gold (Range) n Median # Gold (Range)
Annexin V 175 2 (1–72) 184 4 (1–213) 0.01
Lactadherin 177 3 (1–172) 239 3 (1–53) 0.734
CD54 63 1 (1–12) 140 2 (1–103) < 0.0001
CD105 52 1 (1–26) 67 1 (1–19) 0.998
Table 2. Effect of vesiculation agonist and probe on marker expression and detection. NS: non-
stimulated; TNF: tumour necrosis factor (100 ng/ml). n = the number of MP enumerated per condition. 
Median # gold (range) = the median number and range of gold particles bound per MP. *Kolmogorov-
Smirnov comparison of gold distributions.
Figure 4. Comparative dual labelled FCM and immuno-EM show distinct differences in the percentage 
of Ag+ MP. (a) Purified MP samples dual immuno-labelled with either annexin V or lactadherin (10 nm 
gold, closed arrowheads) followed by anti-CD54 or CD105 Abs (15 nm gold, open arrowheads) were 
negatively labelled and imaged at 100 000 X Mag on the JEOL 1400 TEM. (b,c) The percentages of PS+ 
(dark grey), double + (light grey) and Ag + (white) were determined from the total numbers of MP analysed 
for each marker combination and for both the FCM (n = 3) and immuno-EM (n = 1) experiments. CD54 
data is shown on the top row whilst CD105 is below for both annexin V (b) and lactadherin (c) labels.
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The striking and consistent difference between the two analytic methods is the higher proportion of 
MP which are solely labelled for the Ag in the immuno-EM experiments. These MP are examined further 
in Table 3 which summarises their size distributions (range of maximum Feret diameter in μ m) and the 
number of gold bound per MP. The median diameter for the CD54 labelled MP is 0.273 μ m and median 
number of gold bound was 2, whilst a median of 1 gold was bound in the CD105 only population which 
had a median diameter of 0.25 μ m.
Discussion
The limitations of MP detection are persistently being tested by improvements to the physical compo-
nents and analytical parameters of new generation flow cytometers. Improved sensitivity of the Gallios 
FCM in detecting MP has been shown previously24. Employing the wide2 FS detector with triggering 
events set on the SS channel improved the dynamic range of detection and reduced the resolution limit to 
~300 nm. Whilst the authors of this work sought to demonstrate applicability of this high-sensitivity sys-
tem in clinical settings, our work aimed to provide novel assessment of a selection of currently employed 
probes and in turn assess the strengths and weaknesses of high-sensitivity FCM.
The technically challenging and laborious nature of quantitative immuno-EM makes it a less favour-
able method for routine MP analysis. The study employed a whole mount negative staining method 
adopted from immuno-EM works used to validate Ag expression on MP27,28, and is comparable to studies 
specifically examining exosomes29,30. The primary benefit of this technique is that MP can be visualised 
in their entirety within 2-dimensions, without the need for resin embedding and sample sectioning, 
which is not only time consuming but can affect both image interpretation and gold quantification31,32. 
Drawbacks include the use of chemical fixation, which compromises membrane integrity, along with 
the low labelling efficiency of immuno-gold tagging. Although efficiency is estimated to be as low as 
10–15% it is shown to be constant and reproducible if sample processing is standardised33,34. This means 
that whilst true Ag levels cannot be quantified, the relative expression between different experimental 
conditions and gold tags can be evaluated.
Our analysis demonstrated that of the MP probes examined, PS markers labelled almost all of the 
antibody fluorescent positive MP events, making PS the most efficient MP label in this study. Although 
other immuno-EM studies of annexin V did not quantify the numbers of gold particles bound our results 
are qualitatively comparable with that of Heijnen et al. who utilised a similar methodology. Arraud 
et al. alternatively demonstrate that MP were either heavily labelled or not labelled at all. We believe 
this difference in labelling density to our study is due to the 1) their annexin V being pre-conjugated to 
gold nanoparticles and 2) their use of cryo-EM sample preparation and imaging methods which better 
preserve the membrane integrity.
While high-sensitivity FCM indicates that PS positive MP account for only ~30–55% of the total 
MP population depending on the vesiculation stimulus, immuno-EM data determine this level to be 
higher at 62–65%. These relative PS-positive/-negative proportions vary extensively throughout the MP 
literature. For platelet MP as few as 15–20% express PS on their surface despite the majority of platelets 
being PS positive13,15–17. Arraud et al. estimate that approximately 50% of spherical extracellular vesicles 
(0.03–1 μ m) were PS positive18. Nielsen et al. reported that PS positive MP accounted for 74% of the total 
endothelial MP levels measured, although they also suggested there may have been contamination with 
platelet MP due to CD31+ /CD42- labelling17. A stark difference is that in our relatively ‘pure’ system 
this measure of positivity vs negativity cannot be influenced by other MP types, but rather only by the 
quality of the buffer (i.e. filtered vs. unfiltered PBS) and antibody (a consequence of not washing the 
unbound antibodies). Chandler et al. similarly observed that not all negative MP events appeared to have 
cellular origins16. As such it is necessary to comment one should take care when reporting percentage 
positivity/negativity FCM results. Reporting the absolute numbers of positive MP per volume of plasma 
would overcome this.
By high-sensitivity FCM, annexin V and lactadherin measured comparable levels of absolute MP 












AV + CD54 2 0.2–0.212 1 11 0.115–0.506 1–4
AV + CD105 6 0.19–0.415 1–4 4 0.141–0.296 1–2
Lact + CD54 5 0.204–0.438 1–2 17 0.138–0.516 1–8
Lact + CD105 7 0.184–0.266 1–6 5 0.146–0.446 1
Table 3. Small size distribution and low immunogold binding in the PS-/Ag+ population. NS: 
non-stimulated; TNF: tumour necrosis factor (100 ng/ml). n = the number of double positive MP for 
each labelling combination. #Gold Bound = the range of gold particles counted on MP in each labelling 
combination.
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observation is made after several days of storage and not on fresh samples35. The prominent difference 
that we observed between the two ligands was their labelling intensity in resting versus TNF conditions. 
By both FCM and immuno-EM, MFI and gold values indicated that annexin V labelling was higher on 
TNF MP, whilst lactadherin labelling was unchanged. The differences could not be accounted for by 
changes in size distribution between the two stimuli. Both ligands showed increased labelling on larger 
MP, as expected, however measuring the median fluorescence intensity relative to arbitrary MP size indi-
cated that this difference is more pronounced with annexin V compared to lactadherin. In the literature 
it has been shown that annexin V clustering results in its preferential binding to flat membranes and 
that a threshold of PS must be met for adequate binding, whilst lactadherin has a preference for sharp 
curvatures and binds PS proportionately to the levels available11,36–38. Therefore, from our results we 
propose that the increased labelling intensity of annexin V following TNF activation may be explained 
by, 1) the increased availability of larger and therefore flatter MP, and 2) discrete changes in PS exposure 
at the membrane surface which exceed the required threshold.
In this system, CD105 labelled MP represent a modest 30% of the total marker positive MP popula-
tion, whilst CD54 positive MP encompass between 40–60% depending on the activation stimuli. Thus, 
even in resting condition, on this particular immortalised cell line, CD54 is more highly represented 
on the MP than the constitutively expressed CD105. Consistency in CD105 expression between stimuli 
and upregulation of CD54 following TNF activation were well demonstrated by MFI measurements, 
observations similarly described by Jimenez et al.14. The low FCM detection of Ag-labelled MP was not 
unexpected, as various papers have described similar findings39. For CD105, the relatively low numbers 
of gold particles observed on MP by immuno-EM data corroborate the low expression observed by FCM. 
We believe this weak staining to be a true representation of CD105 expression as a number of antibody 
clones were tested and the same fixation and staining conditions were suitable for the other markers 
examined.
Comparative assessment of FCM and immuno-EM data indicates that the greatest variation between 
the two quantitation methods exists in these Ag single labelled populations. Where they represent 
between 1.5–5% of the total marker positive population by FCM, immuno-EM indicates they in fact 
contribute between 3–19% depending on the marker and stimulus of choice. It cannot be excluded that 
both the difference in antibody clone (for CD105) and conjugation (for CD54) affects the binding affinity 
of these labels. Closer examination of these MP alone found that they were not only on the small end 
of the MP size range but also expressed very low levels of Ag. As size distribution experiments however 
clearly demonstrate no variation between stimulus and MP size in this in vitro system, a finding similarly 
has also been observed for monocytic MP40, it can be reasoned that the size limitation of FCM would 
equally impact both stimulus conditions. Thus if a constitutive marker such as CD105 was to be used to 
analyse MP, an accurate relative expression between conditions could be obtained. The limitation is that 
precise enumeration of the true MP numbers in a sample will not be accurate; however it is clear that 
none of the markers available will achieve this.
It may be that overcoming these FCM limitations requires alternative high throughput analysis tech-
niques. Nanoparticle tracking analysis (NTA) is a laser based method capable of determining particle size 
and suspension concentration through the investigation of vesicle Brownian motions. The use of NTA as 
a quantitative method for MP analysis is currently gaining momentum within the field, particularly as it 
is able to accurately assess events within a 50–1000 nm size range, without the limitations of a detector 
system or refractive index mismatch41,42. The technique is however still in its infancy regarding the use 
of fluorescent markers, and considerable development remains for Ab labelling to be achieved with the 
ease observed in FCM assays.
To summarise, constitutive and PS markers should ideally be used in combination to quantitate 
endothelial MP as data obtained solely with Ag markers do not appear reflective of the true number of 
MP events. An optimal set up would address the issue of FCM sensitivity with multi-colour antibodies or 
monochrome composite markers20. Measures of MFI are more appropriate for the assessment of induc-
ible markers and conclusions should not easily be drawn on the degree of marker ‘negativity’ without 
direct visual confirmation. Annexin V and lactadherin can be used interchangeably if MP raw numbers 
are the primary interest of the study. However if the introduction of calcium is incompatible with the 
system at hand (e.g. EDTA is used as an anti-coagulant) or it is necessary to evaluate the relative levels 
of PS between varying MP, then the use of lactadherin would be preferential.
Ultimately, probe selection for MP FCM analysis remains at the discretion of the researcher and is 
dependent on the overall aims, requirements and outcomes of the study. There is great necessity for 
researchers within the field to form standardised quantitative approaches for MP analysis. Factors that 
must be addressed include how we define MP (and whether this definition solely encompasses PS pos-
itive events), how we collect and store MP, which analytic parameters are used and how we report our 
findings. Only then can a more holistic interpretation and understanding of MP be achieved.
Materials and Methods
Cell Culture. The human cerebral microvascular endothelial cell line, hCMEC/D3, were a kind gift 
of PO Couraud (Institut Cochin, Paris, France) cultured as previously described43,44. Briefly, hCMEC/
D3 were seeded onto rat tail collagen type I (Corning Life Sciences, Cambridge, MA, USA) coated plas-
ticware and maintained in complete EBM-2 supplemented with 5% FCS, 5 μ g/ml ascorbic acid (Sigma, St 
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Louis, MO, USA), 1.4 μ mol/L hydrocortisone (Sigma), CDLC (1:100 dilution; Life technologies, Carlsbad, 
CA, USA), 10 mmol/L HEPES (Sigma) and 1 ng/ml β -FGF (Sigma). Cells were maintained up to passage 
38. Sub-confluent monolayers were activated overnight with 100 ng/ml TNF (Peprotech EC Ltd, London, 
UK) in complete EBM-2 medium to increase MP release.
Flow Cytometry (FCM). Culture supernatants were collected and homogenized by gentle pipet-
ting to ensure even MP distribution throughout the supernatant. Samples (100 μ l of culture superna-
tant) were stained with either annexin V-FITC (#731725, Beckman Coulter Immunotech, Marseille, 
France) ± CD105-PE (#A07414, Beckman Coulter) or CD54-PE (#IM1239U, Beckman Coulter) in 
the presence of binding buffer (#731726, Beckman Coulter), or lactadherin-FITC (#BLAC-FITC, 
Haematologic Technologies Inc., Essex Jct., VT, USA) ± CD105-PE or CD54-PE in the presence of 
filtered PBS. These antibodies/ligands were at saturating concentrations, as determined by titration. 
Samples were made to a final volume of 200 μ l with PBS and analysed on the Gallios™ flow cytometer. 
Six replicate wells were analysed across 3 separate experiments.
Employing the wide2 forward scatter detector, samples were measured over 120 seconds at a medium 
flow rate. Instrument detection was triggered on side scatter (SS), which was set at a threshold of 6, the 
lowest possible value where neither the background nor the numbers of positive events were altered. The 
acquisition rate did not exceed 1000 events per second. A flow rate of 18.5 μ l/min was determined with 
Flowcount beads® (Beckman Coulter) as previously described45.
On a logarithmic scale, forward scatter (FS) was plotted against SS. Despite varying in their light 
scattering properties from plasma membrane vesicles, fluorescent nano-particles (Spherotech® beads, 
0.21, 0.45, 0.88 and 1.34 μ m in diameter) were used to set the limits of the MP size gate and ensure 
system stability (Fig.  5a). The electronic noise of the instrument was determined with PBS (Fig.  5b) 
and unlabelled cell culture supernatant, in which large debris were removed by a 1800 g 10 min spin, 
was used to define the analysis window of MP (Fig. 5c). In FCM, the relative size of a cell or particle is 
determined by the intensity of light scattering detected by the FS detector. In this manuscript we have 
employed both the terms “size” and “relative size” keeping this in mind. To determine the relationship 
between the relative size of MP and their level of fluorescence, we define arbitrary gates on the FS axis 
(A to E, Fig. 5d) and measured the median fluorescence intensity of each subpopulation for each marker 
in stimulated conditions (Fig. 1d).
Swarm detection is a major issue when small events are analysed. In addition to using a medium 
flow rate as described above, we have taken the following precautions to ensure that we are not counting 
coincident events: (1) we perform serial dilutions of our labelled supernatants or biological samples to 
find the optimal dilution from which we have a linear correlation between the dilution factor and the 
numbers of positive events detected (Fig. 5e) and (2) we use the Time of Flight (TOF) parameter of the 
Gallios flow cytometer, which measures the transit time of a cell or particle traversing the laser beam. 
This parameter allows the detection of doublets and other coincident events. Particles of a uniform size 
will have an equivalent TOF (Fig.  5f, single MP gate) whilst samples that are in the laser beam at the 
same time have less total light and take longer to traverse the laser beam (Fig. 5f, coincident events gate). 
Within the labelled MP, this coincident event population never exceeds 2% of the total labelled events.
Figures 5g and 5h show various combinations of labelling with both PS markers and surface Ag as 
well as resting and stimulated conditions. FL1 (FITC) was plotted against FL2 (PE) within each sample. 
Samples were compensated post-acquisition against single labelled, unstained and IgG-matched con-
trols. Buffer only controls consistently lead to 30–50 events per second. The events were disregarded in 
analysis as they were not positive for fluorescence and did not modulate the numbers of positive events. 
FL1 + /FL2- MP expressed PS alone (PS+ ), FL1 + /FL2+ MP were positive for both the CD marker 
and PS (double), whilst FL1-/FL2 + MP solely displayed the Ag on their surface (Ag+ ). MP numbers 
were expressed per 103 cells. To allow reproducibility between instruments, we have analysed in our 
acquisition protocol Spherotech RCP-30-5A beads that contain 8 levels of fluorescence. Corresponding 
molecule equivalent surface fluorescence (MESF) values have been calculated for both FITC and PE 
channels and the corresponding data are reported in Table 4.
Microparticle Purification. MP were purified from hCMEC/D3 culture supernatants as previously 
described44. Briefly, large cellular debris were removed at 1800 g for 10 min before supernatants were spun 
for 45 min at 18,000 g. MP pellets were resuspended by gently pipetting in 1 ml of PBS, sample purity was 
confirmed by FCM based on size and samples were furthermore spun for 45 min at 18,000 g.
Transmission Electron Microscopy (TEM). Purified MP were resuspended in PBS (approx. 
3000 MP/μ l as estimated by annexin V labelling by FCM) and adsorbed onto formvar-carbon coated 
nickel 300 mesh grids (5 μ l/grid; Proscitech, Thuringowa, Qld, Australia) for 20 min. Labelling with 
annexin V-Biotin (#556417, BD Pharmingen, San Diego, CA, USA) in the presence of binding buffer or 
lactadherin-FITC in the presence of PBS was performed for 30 min at RT prior to fixation. Grids were 
fixed in 2% PFA for 15 min, washed with PBS, quenched in 0.05 M glycine for 15 min, blocked in 2% 
BSA in PBS for 30 min and incubated in 10 μ g/ml of the following primary Ab in blocking buffer for 1 h 
at RT: CD105 (#sc-20072, Santa Cruz Biotechnology, Santa Cruz, CA, USA); CD54 (#IM0544, Beckman 
Coulter,) and CD235a (#IM2210, Beckman Coulter). Samples were washed twice in blocking buffer prior 
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to incubation in Goat-anti-Mouse-IgG-gold 15 nm (#815–022, Aurion, Wageningen, The Netherlands) 
and GAM-streptavidin-gold 10 nm (#810–099, Aurion) for 1 h at RT. Grids were washed with PBS and 
fixed with 2% Glutaraldehyde. For lactadherin-FITC labelled samples, grids were again quenched prior 
to secondary conjugation with a mouse-anti-FITC-IgG-gold 15 nm (#810.233, Aurion). Samples were 
washed with water prior to negative staining with 2% Uranyl Acetate for 3 min at RT.
All TEM images were collected with the JEOL 1400 (JEOL, Tokyo, Japan) at 120 kV at the AMMRF 
facility at the University of Sydney. Single labelled samples were imaged at 60,000 X Mag whilst double 
labelled samples were imaged at 100,000 X Mag, as determined by optimisation experiments.
Image Analysis. Image J software was utilised for all immuno-EM MP quantification and analysis. 
Briefly, MP regions of interest (ROI) were manually selected and the diameter and number of gold par-
ticles bound per MP were measured. Feret’s diameter was selected as the preferred measurement over 
Figure 5. Flow cytometry setup (methods) (a–d) Definition of the MP gate on FSC vs SSC cytograms. 
(a) Fluorescent beads were used to set the protocol and allow evaluation of its stability. (b) PBS analysis 
demonstrates the purity of the machine where all the events detected correspond to the electronic noise of 
the instrument. (c) Analysis of a cell culture supernatant shows that the majority of the events fall with the 
MP gate. (d) Arbitrary gates (a–e) divide the MP gate to assess the relationship between MP size and Ag 
labelling. (e,f) examples of excluding swarm detection. (e) Number of MP positive for Annexin V detected 
in a serial dilution of the culture supernatant. (f) The time of Flight (TOF) parameter within a positive MP 
population where the left gate represent the single events and the right gate indicates the coincident events. 
(g,h) Examples of labelling combinations. CD105 vs annexin V and lactadherin on TNF-stimulated cells 
(g, left and right respectively). CD54 vs annexin V staining on resting vs TNF-stimulated cells (h, left and 
right respectively). MP were counted in the upper left quadrant for Ag only (Ag+ ), upper right for double 
labelled (double), lower right of PS marker only (PS+ ) and lower left for negative (Neg).
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alternatives such as perimeter and area, as MP diameter is the most common gauge of MP size in the 
literature. Particles with minimum or maximum Feret’s diameter values outside of the 100–2000 nm 
range were excluded from the analysis, regardless of gold binding.
Statistical Analyses. Statistical analyses were performed with Graph Pad Prism 5 (Graphpad 
Software Inc, CA, USA) and IBM SPSS v20.0 (IBM, NY, USA) software. In each case, data normality 
was determined prior to application of the appropriate statistical test. MP numbers as determined by 
FCM were assessed with a one-way ANOVA and Bonferroni’s correction for multiple comparisons when 
data assumed a normal distribution or with the non-parametric Kruskal-Wallis test followed by Dunn’s 
test for multiple comparisons. All correlations were performed with the nonparametric Spearman’s test. 
All comparisons between two conditions were achieved with either the Students t test or Mann Whitney 
nonparametric test. Gold distributions were compared with the Kolmogorov-Smirnov test. All tests were 
two-tailed and the level of significance was set at p value < 0.05. All graphical representations were pro-
duced in Graph Pad Prisms 5. In the text standard error of the mean is denoted with SE and standard 
deviation with SD.
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